Thomas Flaten
Stock Analyst at Lake Street
(0)
# 4389
Out of 5,270 analysts
39
Total ratings
31.03%
Success rate
-10.70%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Evaxion Biotech | Maintains: Buy | 35 6 | 1.89 | 217.46% | 2 | Feb 4, 2025 | |
OptiNose | Maintains: Buy | 45 17 | 5.42 | 213.65% | 4 | Jan 16, 2025 | |
Personalis | Maintains: Strong Buy | 7 9 | 4.08 | 120.59% | 2 | Jan 8, 2025 | |
Checkpoint Therapeut... | Maintains: Strong Buy | 4 7 | 2.58 | 171.32% | 4 | Dec 16, 2024 | |
Castle Biosciences | Maintains: Strong Buy | 34 40 | 21.58 | 85.36% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 5.29 | 70.13% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1 | n/a | n/a | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 0.77 | 289.61% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 8 | 2.7 | 196.3% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 11 | 2.88 | 281.94% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 25 | 25.55 | -2.15% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 60 10 | 2.74 | 264.96% | 4 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14400 1440 | 5.12 | 28025% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 8 | 6.5 | 23.08% | 1 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | May 13, 2022 |